163 related articles for article (PubMed ID: 21211555)
1. Antiplatelet effects of Spatholobus suberectus via inhibition of the glycoprotein IIb/IIIa receptor.
Lee BJ; Jo IY; Bu Y; Park JW; Maeng S; Kang H; Jang W; Hwang DS; Lee W; Min K; Kim JI; Yoo HH; Lew JH
J Ethnopharmacol; 2011 Mar; 134(2):460-7. PubMed ID: 21211555
[TBL] [Abstract][Full Text] [Related]
2. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2.
Oh CH; Shin JI; Mo SJ; Yun SJ; Kim SH; Rhee YH
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):498-504. PubMed ID: 23412354
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo.
Park MK; Rhee YH; Lee HJ; Lee EO; Kim KH; Park MJ; Jeon BH; Shim BS; Jung CH; Choi SH; Ahn KS; Kim SH
Phytother Res; 2008 Jan; 22(1):58-64. PubMed ID: 17724769
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIb/IIIa receptor inhibitor attenuates platelet aggregation induced by thromboxane A2 during in vitro nonpulsatile ventricular assist circulation.
Yomo T; Serna DL; Powell LL; Wang D; Wilson SE; Ishimaru S; Chen JC
Artif Organs; 2000 May; 24(5):355-61. PubMed ID: 10848676
[TBL] [Abstract][Full Text] [Related]
7. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
[TBL] [Abstract][Full Text] [Related]
9. The in vitro and in vivo pharmacological profiles of a platelet glycoprotein IIb/IIIa antagonist, NSL-9403.
Katada J; Takiguchi Y; Muramatsu M; Fujiyoshi T; Uno I
Thromb Res; 1997 Oct; 88(1):27-40. PubMed ID: 9336871
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
[TBL] [Abstract][Full Text] [Related]
11. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty.
Byrne A; Moran N; Maher M; Walsh N; Crean P; Fitzgerald DJ
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3224-9. PubMed ID: 9409315
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
Proimos G
J Thromb Thrombolysis; 2001 Apr; 11(2):99-110. PubMed ID: 11406724
[TBL] [Abstract][Full Text] [Related]
13. Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity.
Mousa SA; Forsythe M; Lorelli W; Bozarth J; Xue CB; Wityak J; Sielecki TM; Olson RE; DeGrado W; Kapil R; Hussain M; Wexler R; Thoolen MJ; Reilly TM
Coron Artery Dis; 1996 Oct; 7(10):767-74. PubMed ID: 8970768
[TBL] [Abstract][Full Text] [Related]
14. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
[TBL] [Abstract][Full Text] [Related]
15. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet mechanism of 2-chloro-3-(4-hexylphenyl)-amino-1,4-naphthoquinone (NQ304), an antithrombotic agent.
Zhang YH; Chung KH; Ryu CK; Lee YH; Kim TJ; Song YS; Hwang KA; Yun YP
Pharmacol Toxicol; 2001 Apr; 88(4):181-6. PubMed ID: 11322175
[TBL] [Abstract][Full Text] [Related]
17. Human platelet alphaIIbeta3 integrin binding affinity and specificity of SJ874: antiplatelet efficacy versus aspirin.
Mousa SA; Forsythe M; Bozarth J; Jin F; Confalone PN
Coron Artery Dis; 2000 Oct; 11(7):563-70. PubMed ID: 11023245
[TBL] [Abstract][Full Text] [Related]
18. Effects of a new platelet glycoprotein IIb/IIIa antagonist, SR121566, on platelet activation, platelet-leukocyte interaction and thrombin generation.
Li N; Wallén NH; Savi P; Hérault JP; Herbert JM
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):507-15. PubMed ID: 9819001
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase.
Kang WS; Chung KH; Chung JH; Lee JY; Park JB; Zhang YH; Yoo HS; Yun YP
J Cardiovasc Pharmacol; 2001 Dec; 38(6):875-84. PubMed ID: 11707691
[TBL] [Abstract][Full Text] [Related]
20. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
